If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dawit Aregawi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Polycystic Ovary Syndrome Medicine & Life Sciences
Metformin Medicine & Life Sciences
Pseudotumor Cerebri Medicine & Life Sciences
Diet Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Leukemic Infiltration Medicine & Life Sciences
Thrombophilia Medicine & Life Sciences
Hyperinsulinism Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 498 Citations
  • 12 h-Index
  • 16 Article
  • 3 Chapter
  • 1 Comment/debate
  • 1 Letter
1 Citation (Scopus)

MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors

Payne, R., Mrowczynski, O. D., Slagle-Webb, B., Bourcier, A., Mau, C., Aregawi, D., Madhankumar, A., Lee, S. Y., Harbaugh, K., Connor, J. & Rizk, E., Feb 1 2019, In : Journal of neurosurgery. 130, 2, p. 465-475 11 p.

Research output: Contribution to journalArticle

Neurilemmoma
Ifosfamide
Aurora Kinase A
Doxorubicin
Therapeutics

Spinal metastasis as complication of systemic cancers

Davis, G., Lee, M., Aregawi, D., Shaffrey, M. E., Schiff, D. & Sherman, J. H., Sep 16 2017, Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment: Third Edition. Springer International Publishing, p. 113-125 13 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Neoplasm Metastasis
Neoplasms
16 Citations (Scopus)

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

Odia, Y., Kreisl, T. N., Aregawi, D., Innis, E. K. & Fine, H. A., Oct 1 2015, In : Journal of neuro-oncology. 125, 1, p. 191-195 5 p.

Research output: Contribution to journalArticle

Tamoxifen
Glioma
Medical Futility
Hypophosphatemia
Karnofsky Performance Status
106 Citations (Scopus)

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: A multi-center study

Pope, W. B., Qiao, X. J., Kim, H. J., Lai, A., Nghiemphu, P., Xue, X., Ellingson, B. M., Schiff, D., Aregawi, D., Cha, S., Puduvalli, V. K., Wu, J., Yung, W. K. A., Young, G. S., Vredenburgh, J., Barboriak, D., Abrey, L. E., Mikkelsen, T., Jain, R., Paleologos, N. A. & 5 others, Rn, P. L., Prados, M., Goldin, J., Wen, P. Y. & Cloughesy, T., Jul 1 2012, In : Journal of neuro-oncology. 108, 3, p. 491-498 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Disease-Free Survival
Survival
Bevacizumab
Normal Distribution

Neurological complications of solid tumors

Aregawi, D., Sherman, J. H. & Schiff, D., Jan 1 2012, Handbook of Clinical Neurology. Elsevier B.V., p. 683-710 28 p. (Handbook of Clinical Neurology; vol. 105).

Research output: Chapter in Book/Report/Conference proceedingChapter

Nervous System Neoplasms
Nervous System Diseases
Neoplasm Metastasis
Neoplasms